Physician profile
Thomas J Gresham
NPI 1952384232
$2,448.42
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.52 · 2022: $1,360 · 2023: $1,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,075.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,075.02 | 2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals Lp | $437.48 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.29 | 2022 | |
| Glaxosmithkline, LLC. | $134.36 | 2022 | |
| Mylan Specialty L.P. | $122.99 | 2022 | |
| Genentech USA, INC. | $71.43 | 2022 | |
| Electromed, INC. | $66.38 | 2022 | |
| United Therapeutics Corporation | $64.49 | 2022 | |
| Mallinckrodt Hospital Products INC. | $47.78 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.48 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $38.23 | 2022 | |
| Baxter Healthcare | $33.21 | 2022 | |
| Cook Medical LLC | $31.91 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.17 | 2022 | |
| Amgen INC. | $16.13 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $14.88 | 2022 | |
| Philips North America LLC | $14.05 | 2022 | |
| Abbott Laboratories | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gresham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.